The Unitaid-funded ASCENT project has entered its final year and is well on its way in showing the benefits in helping people affected by TB with their treatment by using digital adherence technology such as smart pill boxes, medication sleeves and video supported treatment.
Budgeting tool for digital adherence technologies released
The ASCENT project releases a free Total Cost of Ownership (TCO) Tool, to enable accurate budget forecasting for the implementation and use of Digital Adherence Technologies (DATs) in TB treatment.
Smart medication container included in GDF product catalog
The Stop TB Partnership and the ASCENT project are proud to announce the introduction of an easy and efficient way to procure digital adherence technologies.
Virtual meeting to prepare ASCENT study activities
In July, the ASCENT project organized a virtual meeting for all Research Managers to prepare the study activities that will be conducted in the different ASCENT countries.
Successful TB REACH projects test how DATs work in the fight against TB
Since 2018, KNCV has rolled-out several Digital Adherence Technology (DAT) demonstration projects in countries such as the Philippines and Tanzania
’99DOTS digital technology helped me get cured of TB’
Angelito: “Thanks to nurse Anton’s warm support, and my family’s constant encouragement, I didn’t give up. And thanks, too, for 99DOTS.
First smart pill boxes arrive in Tanzania
A first shipment of 500 boxes – that will help TB patients with their treatment adherence – got delivered to the KNCV office in Dar es Salaam.
Innovative TB treatment support project kicks off in the Philippines
The ASCENT project announces a Request for Proposals (RFP) for Provision of hosting services for the ASCENT Digital Adherence Platform.
Requests for quotations
The ASCENT project has two requests for quotation (RFQ’s): 1. For printing of cardstock medication sleeves. 2. To facilitate incoming and outgoing interactions with an adherence platform.
ASCENT: Empowering patients through digital technology
The next three and a half years, KNCV Tuberculosis Foundation will lead the innovative ASCENT project.